Q4 2027
Ends Dec 31, 2027
Revenue
$0.0B
$0.0B to $0.0B
EPS
-0.03
-0.03 to -0.03
No analyst count
EPS: No analyst count
May 5, 11:25 PM UTC
stable/analyst-estimates
Healthcare
Live Price
Offline$6.48
-1.97% today
Window Change
+96.00%
Window
Jul 2, 2025 → May 22, 2026
Coverage: 225 bars · Jul 2, 2025 → May 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
CapsoVision, Inc. (CV) is a fund with a market cap of $350.00M and listed on NASDAQ. The fund last traded around $6.48 and up 96.0% across the available one-year price window (Jul 2, 2025 → May 22, 2026). Valuation already assumes a fairly strong business story at price/sales 26.0. Stock Foundry combines CV price history, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
CV
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
CV Max Drawdown
-67.82%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for CV and SPY.
EPS Consensus
-0.03
Range -0.03 → -0.03
No analyst count
vs prior: +9.5%Revenue Outlook
$0.0B
Range $0.0B → $0.0B
No analyst count
vs prior: +20.8%Consensus Spread
Lower spread suggests tighter agreement across covering analysts.
Trend
Consensus average across visible periods
Trend
Average analyst revenue estimate
Timeline
Sorted by period end date. Includes both cached rows and live fallbacks from FMP.
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.